contamination
Pathogen Safety Today
October 09 by Pharmaceuticals & Biotechnology EditorAs pathogens continue to adapt and develop so must your strategy to prevent contamination. With both the financial cost and the damage to reputation so high is it critical to keep at the cutting edg...
Pathogen Safety: Raw Materials - A Pathogen or Viral Threat?
September 10 by Andrea CharlesImplementing effective pathogen safety strategies is essential for preventing contamination and ensuring the safety of your biologics. Raw materials can bring a pathogen or virus into your manufacturi...
Mitigating the Risks of Contamination in Biopharma
October 18 by Pharma IQA crucial consideration in any pharmaceutical manufacturing process, and particularly when work involves biological elements, is how to mitigate the risk of contamination. Experts predict that within...
62.5% of Biologics Professionals Have Strategy in Place to Mitigate Risks of Contamination
September 06 by Pharma IQWithin the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book. As innovation brings down production costs a...
Ensuring Adventitious Agent Safety in Biologics
July 26 by Pharma IQBy 2015, the global market for biologics is expected to reach $239 billion (£147 billion), thanks to more comprehensive drugs pipelines, development of biosimilars and innovations to slash production...